Cargando…
Changes in Provider Treatment Patterns for Dupuytren’s Contracture: Analysis of Trends in Medicare Beneficiaries
BACKGROUND: Collagenase Clostridium histolyticum (CCH) injection has been shown to be a safe and effective treatment option for Dupuytren’s contracture. We hypothesize that the gaining popularity of CCH has resulted in a change in treatment patterns among providers, with increased utilization of CCH...
Autores principales: | Thayer, Mary Kate, Somerson, Jeremy S., Huang, Jerry I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250467/ https://www.ncbi.nlm.nih.gov/pubmed/30534492 http://dx.doi.org/10.1097/GOX.0000000000001932 |
Ejemplares similares
-
Dupuytren's Contracture
por: Sood, Aditya, et al.
Publicado: (2013) -
Dupuytren's contracture
por: Raina, Sujeet, et al.
Publicado: (2012) -
Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
por: Zah, Vladimir, et al.
Publicado: (2022) -
Dupuytren’s Contracture with Secondary Ulnar Neuropathy
por: Ng, Chen Fei
Publicado: (2020) -
Dupuytren's Contracture: The Readability of Online Information
por: Hosseinzadeh, Shayan, et al.
Publicado: (2021)